Risk Management Plans
Explore all topics, guides, and frameworks related to Risk Management Plans.
Articles in this section
14- Types of Risk Management Plans Explains the single EU RMP framework and how proportionality, legal basis, product characteristics and lifecycle context change which RMP modules, safety concerns and activities are needed. Read Article →
- Safety Specification Explains the purpose and structure of the EU RMP Safety Specification, how evidence is translated into focused safety concerns, and how those concerns connect to pharmacovigilance and risk minimisation planning. Read Article →
- RMP Lifecycle Management Explains how the EU RMP changes across the medicinal-product lifecycle, when updates may be needed, how evidence drives reclassification or removal of safety concerns and how lifecycle decisions connect to regulatory procedures. Read Article →
- RMP Governance and Version Control Explains how organisations can maintain traceability, version integrity, regulatory consistency and QPPV oversight across the RMP lifecycle while distinguishing required outcomes from company-specific governance models. Read Article →
- Risk Minimisation Effectiveness Evaluation Explains the current GVP framework for risk minimisation effectiveness evaluation, including process and outcome indicators, study design, success criteria, interpretation and lifecycle decisions. Read Article →
- Risk Management Plans (RMPs) Explains how the EU RMP documents important risks and missing information, links them to pharmacovigilance and risk-minimisation activities, evolves across the product lifecycle and supports evidence-based benefit-risk management. Read Article →
- PASS and Risk Management Plans Explains when a post-authorisation safety study is appropriate, how PASS objectives should derive from RMP uncertainties, how imposed and non-imposed studies differ, and how study results feed back into risk management. Read Article →
- Missing Information Explains how missing information is selected for the EU RMP, why absence of data alone is insufficient, how clinically relevant uncertainty is linked to pharmacovigilance planning, and how items are retained, refined or removed as evidence develops. Read Article →
- Important Potential Risks Explains how important potential risks are selected for the EU RMP, how evidence and uncertainty are assessed, how they connect to signal management and pharmacovigilance planning, and how they are retained, reclassified or removed as knowledge develops. Read Article →
- Important Identified Risks Explains how important identified risks are distinguished from other adverse reactions and safety concerns, how the evidence and clinical importance are assessed, and how the classification is used through the EU RMP lifecycle. Read Article →
- EU Risk Management Plan Structure Explained The EU Risk Management Plan is a structured regulatory document that connects the product's safety specification to pharmacovigilance activities, risk minimisation and post-authorisation evidence generation. This article explains the current EU RMP architecture, the purpose of every part and module, proportionality for different products and lifecycle stages, and how an experienced PV professional maintains traceability across the document. Read Article →
- Country-Specific RMP Annexes Country-specific RMP documentation should be understood as a controlled local adaptation of an approved risk-management strategy, not as a universally standardised annex format. This article explains the EU RMP annex framework, distinguishes formal RMP annexes from local supplements and implementation records, and shows how global and local teams can govern jurisdiction-specific commitments without fragmenting the scientific risk-management strategy. Read Article →
- Additional Pharmacovigilance Activities in the EU Risk Management Plan Understand when routine pharmacovigilance is insufficient, how additional activities answer defined safety questions, how they relate to RMP Parts III and IV, and what evidence demonstrates effective oversight. Read Article →
- Additional Risk Minimisation Measures in the EU Understand when routine measures are insufficient, how additional risk minimisation measures are connected to safety concerns and objectives, how they are implemented across Member States, and how effectiveness is evaluated. Read Article →